| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | RNA splicing | SFSWAP CCNL2 RBM12B CRNKL1 SRSF11 LUC7L2 RBM39 SCAF11 SRRM4 CLK4 RSRC1 | 4.35e-14 | 502 | 18 | 11 | GO:0008380 |
| GeneOntologyBiologicalProcess | RNA processing | SFSWAP CCNL2 SAGE2P RBM12B CRNKL1 SRSF11 LUC7L2 RBM39 SCAF11 SRRM4 CLK4 RSRC1 | 2.58e-10 | 1500 | 18 | 12 | GO:0006396 |
| GeneOntologyBiologicalProcess | mRNA processing | 8.52e-09 | 551 | 18 | 8 | GO:0006397 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.21e-08 | 358 | 18 | 7 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.21e-08 | 358 | 18 | 7 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 1.30e-08 | 362 | 18 | 7 | GO:0000375 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.60e-08 | 207 | 18 | 6 | GO:0043484 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 4.35e-07 | 917 | 18 | 8 | GO:0016071 | |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 1.45e-06 | 99 | 18 | 4 | GO:0000245 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 4.23e-05 | 79 | 18 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 5.13e-05 | 244 | 18 | 4 | GO:0022618 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 6.00e-05 | 254 | 18 | 4 | GO:0071826 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.82e-04 | 129 | 18 | 3 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 3.31e-04 | 158 | 18 | 3 | GO:0050684 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 8.90e-04 | 515 | 18 | 4 | GO:0022613 | |
| GeneOntologyBiologicalProcess | mRNA splice site recognition | 9.29e-04 | 52 | 18 | 2 | GO:0006376 | |
| GeneOntologyBiologicalProcess | regulation of centrosome cycle | 1.36e-03 | 63 | 18 | 2 | GO:0046605 | |
| GeneOntologyBiologicalProcess | neuron maturation | 1.87e-03 | 74 | 18 | 2 | GO:0042551 | |
| GeneOntologyCellularComponent | nuclear speck | 3.95e-08 | 431 | 18 | 7 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear body | 3.50e-07 | 903 | 18 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 3.11e-03 | 97 | 18 | 2 | GO:0005684 | |
| Domain | RRM_1 | 5.61e-04 | 208 | 15 | 3 | PF00076 | |
| Domain | RRM | 6.35e-04 | 217 | 15 | 3 | SM00360 | |
| Domain | RRM_dom | 7.24e-04 | 227 | 15 | 3 | IPR000504 | |
| Domain | RRM | 7.52e-04 | 230 | 15 | 3 | PS50102 | |
| Domain | - | 8.92e-04 | 244 | 15 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.05e-03 | 258 | 15 | 3 | IPR012677 | |
| Domain | Ser/Thr_kinase_AS | 3.25e-02 | 357 | 15 | 2 | IPR008271 | |
| Domain | S_TKc | 3.28e-02 | 359 | 15 | 2 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 3.33e-02 | 362 | 15 | 2 | PS00108 | |
| Domain | Pkinase | 3.66e-02 | 381 | 15 | 2 | PF00069 | |
| Pathway | WP_MRNA_PROCESSING | 2.16e-05 | 451 | 12 | 5 | MM15946 | |
| Pathway | WP_MRNA_PROCESSING | 1.45e-04 | 126 | 12 | 3 | M39406 | |
| Pathway | REACTOME_MRNA_SPLICING | 5.71e-04 | 201 | 12 | 3 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 6.67e-04 | 212 | 12 | 3 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.45e-03 | 277 | 12 | 3 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.54e-03 | 283 | 12 | 3 | M13087 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 4.06e-03 | 114 | 12 | 2 | MM15361 | |
| Pubmed | 1.13e-10 | 57 | 19 | 5 | 21555454 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 8.77e-09 | 1294 | 19 | 9 | 30804502 | |
| Pubmed | Splicing factor TRA2B is required for neural progenitor survival. | 1.33e-07 | 19 | 19 | 3 | 23818142 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.39e-07 | 807 | 19 | 7 | 22681889 | |
| Pubmed | 1.93e-07 | 847 | 19 | 7 | 35850772 | ||
| Pubmed | 2.82e-07 | 104 | 19 | 4 | 31365120 | ||
| Pubmed | 4.86e-07 | 300 | 19 | 5 | 28561026 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.00e-06 | 1082 | 19 | 7 | 38697112 | |
| Pubmed | 1.81e-06 | 731 | 19 | 6 | 29298432 | ||
| Pubmed | 3.83e-06 | 832 | 19 | 6 | 36724073 | ||
| Pubmed | 4.32e-06 | 206 | 19 | 4 | 34185411 | ||
| Pubmed | 4.84e-06 | 1371 | 19 | 7 | 36244648 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.03e-05 | 989 | 19 | 6 | 36424410 | |
| Pubmed | 1.15e-05 | 81 | 19 | 3 | 26990986 | ||
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 1.24e-05 | 269 | 19 | 4 | 29511261 | |
| Pubmed | Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. | 1.55e-05 | 11 | 19 | 2 | 14729963 | |
| Pubmed | A novel SR-related protein is required for the second step of Pre-mRNA splicing. | 1.86e-05 | 12 | 19 | 2 | 15798186 | |
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 2.20e-05 | 13 | 19 | 2 | 20516191 | |
| Pubmed | 3.27e-05 | 713 | 19 | 5 | 29802200 | ||
| Pubmed | 3.35e-05 | 347 | 19 | 4 | 16033648 | ||
| Pubmed | 3.50e-05 | 723 | 19 | 5 | 34133714 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.91e-05 | 361 | 19 | 4 | 26167880 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 5.19e-05 | 1318 | 19 | 6 | 30463901 | |
| Pubmed | 1.05e-04 | 1497 | 19 | 6 | 31527615 | ||
| Pubmed | Methylation of the DNA/RNA-binding protein Kin17 by METTL22 affects its association with chromatin. | 1.22e-04 | 30 | 19 | 2 | 24140279 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.30e-04 | 954 | 19 | 5 | 36373674 | |
| Pubmed | 2.00e-04 | 551 | 19 | 4 | 34728620 | ||
| Pubmed | 2.40e-04 | 225 | 19 | 3 | 25277244 | ||
| Pubmed | 2.43e-04 | 226 | 19 | 3 | 31452512 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 2.85e-04 | 605 | 19 | 4 | 28977666 | |
| Pubmed | 3.04e-04 | 244 | 19 | 3 | 29884807 | ||
| Pubmed | 3.30e-04 | 251 | 19 | 3 | 31076518 | ||
| Pubmed | 3.55e-04 | 51 | 19 | 2 | 34316707 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 3.58e-04 | 258 | 19 | 3 | 37794589 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 3.62e-04 | 259 | 19 | 3 | 30404004 | |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 4.69e-04 | 283 | 19 | 3 | 28533407 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 4.82e-04 | 695 | 19 | 4 | 23602568 | |
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 4.91e-04 | 60 | 19 | 2 | 29055695 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 4.98e-04 | 701 | 19 | 4 | 30196744 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 5.34e-04 | 714 | 19 | 4 | 28302793 | |
| Interaction | SRRM4 interactions | 3.05e-13 | 37 | 17 | 6 | int:SRRM4 | |
| Interaction | JMJD6 interactions | 2.25e-12 | 205 | 17 | 8 | int:JMJD6 | |
| Interaction | RNPS1 interactions | 1.59e-11 | 425 | 17 | 9 | int:RNPS1 | |
| Interaction | DHX8 interactions | 3.83e-11 | 292 | 17 | 8 | int:DHX8 | |
| Interaction | PNN interactions | 5.01e-11 | 302 | 17 | 8 | int:PNN | |
| Interaction | RBM39 interactions | MCPH1 PNISR RBM12B CRNKL1 SRSF11 LUC7L2 RBM39 SRRM4 NKTR RSRC1 | 1.83e-09 | 1042 | 17 | 10 | int:RBM39 |
| Interaction | SNRNP40 interactions | 1.80e-08 | 637 | 17 | 8 | int:SNRNP40 | |
| Interaction | SNRNP70 interactions | 2.59e-08 | 984 | 17 | 9 | int:SNRNP70 | |
| Interaction | ZCCHC10 interactions | 2.69e-08 | 236 | 17 | 6 | int:ZCCHC10 | |
| Interaction | SRPK2 interactions | 4.52e-08 | 717 | 17 | 8 | int:SRPK2 | |
| Interaction | DDX23 interactions | 6.58e-08 | 480 | 17 | 7 | int:DDX23 | |
| Interaction | SRSF6 interactions | 9.06e-08 | 503 | 17 | 7 | int:SRSF6 | |
| Interaction | SRSF4 interactions | 1.12e-07 | 300 | 17 | 6 | int:SRSF4 | |
| Interaction | ZC3H18 interactions | 2.13e-07 | 877 | 17 | 8 | int:ZC3H18 | |
| Interaction | SRSF11 interactions | 5.54e-07 | 203 | 17 | 5 | int:SRSF11 | |
| Interaction | CD2BP2 interactions | 1.07e-06 | 232 | 17 | 5 | int:CD2BP2 | |
| Interaction | LUC7L interactions | 1.32e-06 | 242 | 17 | 5 | int:LUC7L | |
| Interaction | SRPK1 interactions | 1.69e-06 | 477 | 17 | 6 | int:SRPK1 | |
| Interaction | SNRPA interactions | 1.79e-06 | 482 | 17 | 6 | int:SNRPA | |
| Interaction | DOT1L interactions | 2.20e-06 | 807 | 17 | 7 | int:DOT1L | |
| Interaction | SRSF10 interactions | 2.30e-06 | 271 | 17 | 5 | int:SRSF10 | |
| Interaction | MECP2 interactions | 3.91e-06 | 1287 | 17 | 8 | int:MECP2 | |
| Interaction | SRSF1 interactions | 4.73e-06 | 570 | 17 | 6 | int:SRSF1 | |
| Interaction | MYCN interactions | 6.34e-06 | 1373 | 17 | 8 | int:MYCN | |
| Interaction | CSNK2A1 interactions | 6.77e-06 | 956 | 17 | 7 | int:CSNK2A1 | |
| Interaction | NCBP3 interactions | 7.60e-06 | 156 | 17 | 4 | int:NCBP3 | |
| Interaction | LUC7L2 interactions | 8.34e-06 | 353 | 17 | 5 | int:LUC7L2 | |
| Interaction | PNISR interactions | 1.01e-05 | 51 | 17 | 3 | int:PNISR | |
| Interaction | U2AF2 interactions | 1.01e-05 | 651 | 17 | 6 | int:U2AF2 | |
| Interaction | UQCR11 interactions | 1.14e-05 | 53 | 17 | 3 | int:UQCR11 | |
| Interaction | IFI6 interactions | 1.20e-05 | 54 | 17 | 3 | int:IFI6 | |
| Interaction | SNRPF interactions | 1.27e-05 | 385 | 17 | 5 | int:SNRPF | |
| Interaction | SREK1 interactions | 1.43e-05 | 183 | 17 | 4 | int:SREK1 | |
| Interaction | SRPK3 interactions | 1.65e-05 | 190 | 17 | 4 | int:SRPK3 | |
| Interaction | CSNK2A2 interactions | 1.77e-05 | 718 | 17 | 6 | int:CSNK2A2 | |
| Interaction | CLK2 interactions | 1.83e-05 | 195 | 17 | 4 | int:CLK2 | |
| Interaction | SRSF7 interactions | 2.04e-05 | 425 | 17 | 5 | int:SRSF7 | |
| Interaction | IFI27L1 interactions | 2.11e-05 | 65 | 17 | 3 | int:IFI27L1 | |
| Interaction | SON interactions | 2.36e-05 | 208 | 17 | 4 | int:SON | |
| Interaction | CLK1 interactions | 2.89e-05 | 219 | 17 | 4 | int:CLK1 | |
| Interaction | FOLR1 interactions | 3.33e-05 | 227 | 17 | 4 | int:FOLR1 | |
| Interaction | ZRSR2 interactions | 3.51e-05 | 77 | 17 | 3 | int:ZRSR2 | |
| Interaction | U2AF1 interactions | 4.07e-05 | 239 | 17 | 4 | int:U2AF1 | |
| Interaction | SNRPB interactions | 5.22e-05 | 517 | 17 | 5 | int:SNRPB | |
| Interaction | CPSF6 interactions | 5.67e-05 | 526 | 17 | 5 | int:CPSF6 | |
| Interaction | CFAP20 interactions | 5.79e-05 | 91 | 17 | 3 | int:CFAP20 | |
| Interaction | SPPL3 interactions | 5.79e-05 | 886 | 17 | 6 | int:SPPL3 | |
| Interaction | UBR5 interactions | 6.04e-05 | 533 | 17 | 5 | int:UBR5 | |
| Interaction | LINC02910 interactions | 6.58e-05 | 95 | 17 | 3 | int:LINC02910 | |
| Interaction | PPIE interactions | 7.74e-05 | 282 | 17 | 4 | int:PPIE | |
| Interaction | CHD4 interactions | 7.96e-05 | 938 | 17 | 6 | int:CHD4 | |
| Interaction | CCDC12 interactions | 8.61e-05 | 104 | 17 | 3 | int:CCDC12 | |
| Interaction | ARL6IP4 interactions | 9.90e-05 | 109 | 17 | 3 | int:ARL6IP4 | |
| Interaction | SNRPE interactions | 1.05e-04 | 305 | 17 | 4 | int:SNRPE | |
| Interaction | RSRC1 interactions | 1.07e-04 | 112 | 17 | 3 | int:RSRC1 | |
| Interaction | GPATCH8 interactions | 1.16e-04 | 115 | 17 | 3 | int:GPATCH8 | |
| Interaction | CSNK2B interactions | 1.28e-04 | 625 | 17 | 5 | int:CSNK2B | |
| Interaction | PRP4K interactions | 1.40e-04 | 329 | 17 | 4 | int:PRP4K | |
| Interaction | CDC40 interactions | 1.45e-04 | 124 | 17 | 3 | int:CDC40 | |
| Interaction | NKAP interactions | 1.75e-04 | 132 | 17 | 3 | int:NKAP | |
| Interaction | ISY1 interactions | 1.87e-04 | 135 | 17 | 3 | int:ISY1 | |
| Interaction | ZNF677 interactions | 2.32e-04 | 27 | 17 | 2 | int:ZNF677 | |
| Interaction | ARHGAP20 interactions | 2.50e-04 | 28 | 17 | 2 | int:ARHGAP20 | |
| Interaction | TRA2B interactions | 2.56e-04 | 385 | 17 | 4 | int:TRA2B | |
| Interaction | NKAPD1 interactions | 3.13e-04 | 161 | 17 | 3 | int:NKAPD1 | |
| Interaction | PRPF38A interactions | 3.13e-04 | 161 | 17 | 3 | int:PRPF38A | |
| Interaction | SNRPD2 interactions | 3.38e-04 | 414 | 17 | 4 | int:SNRPD2 | |
| Interaction | SNIP1 interactions | 3.47e-04 | 417 | 17 | 4 | int:SNIP1 | |
| Interaction | INO80B interactions | 3.49e-04 | 167 | 17 | 3 | int:INO80B | |
| Interaction | ZC3H14 interactions | 3.61e-04 | 169 | 17 | 3 | int:ZC3H14 | |
| Interaction | RBM22 interactions | 3.61e-04 | 169 | 17 | 3 | int:RBM22 | |
| Interaction | SNRPC interactions | 4.26e-04 | 440 | 17 | 4 | int:SNRPC | |
| Interaction | PRPF19 interactions | 4.63e-04 | 450 | 17 | 4 | int:PRPF19 | |
| Interaction | SRRM2 interactions | 5.12e-04 | 462 | 17 | 4 | int:SRRM2 | |
| Interaction | LSM2 interactions | 5.17e-04 | 191 | 17 | 3 | int:LSM2 | |
| Interaction | SF3A1 interactions | 5.50e-04 | 471 | 17 | 4 | int:SF3A1 | |
| Interaction | CRBN interactions | 5.91e-04 | 200 | 17 | 3 | int:CRBN | |
| Interaction | CLK4 interactions | 6.21e-04 | 44 | 17 | 2 | int:CLK4 | |
| Interaction | ARHGEF26 interactions | 6.21e-04 | 44 | 17 | 2 | int:ARHGEF26 | |
| Interaction | OBSL1 interactions | 7.01e-04 | 902 | 17 | 5 | int:OBSL1 | |
| Interaction | HERC2 interactions | 7.05e-04 | 503 | 17 | 4 | int:HERC2 | |
| Interaction | RNASEH1 interactions | 7.08e-04 | 47 | 17 | 2 | int:RNASEH1 | |
| Interaction | NR2C2 interactions | 7.14e-04 | 1403 | 17 | 6 | int:NR2C2 | |
| Interaction | IK interactions | 7.29e-04 | 215 | 17 | 3 | int:IK | |
| Interaction | ZC3H11A interactions | 7.29e-04 | 215 | 17 | 3 | int:ZC3H11A | |
| Interaction | CLK3 interactions | 7.79e-04 | 220 | 17 | 3 | int:CLK3 | |
| Interaction | SRSF3 interactions | 8.10e-04 | 522 | 17 | 4 | int:SRSF3 | |
| Interaction | UTP14A interactions | 8.86e-04 | 230 | 17 | 3 | int:UTP14A | |
| Interaction | GPATCH11 interactions | 9.34e-04 | 54 | 17 | 2 | int:GPATCH11 | |
| Interaction | DHX40 interactions | 1.11e-03 | 249 | 17 | 3 | int:DHX40 | |
| Interaction | SMC5 interactions | 1.12e-03 | 1000 | 17 | 5 | int:SMC5 | |
| Interaction | DCAF15 interactions | 1.19e-03 | 255 | 17 | 3 | int:DCAF15 | |
| Interaction | RALYL interactions | 1.39e-03 | 66 | 17 | 2 | int:RALYL | |
| Interaction | RBM12B interactions | 1.52e-03 | 69 | 17 | 2 | int:RBM12B | |
| Interaction | KIN interactions | 1.56e-03 | 70 | 17 | 2 | int:KIN | |
| Interaction | SRSF2 interactions | 1.73e-03 | 290 | 17 | 3 | int:SRSF2 | |
| Interaction | SUZ12 interactions | 1.76e-03 | 644 | 17 | 4 | int:SUZ12 | |
| Interaction | FLNA interactions | 1.80e-03 | 648 | 17 | 4 | int:FLNA | |
| Interaction | PPP2R2A interactions | 1.92e-03 | 301 | 17 | 3 | int:PPP2R2A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 1.26e-02 | 415 | 19 | 2 | chr12q24 | |
| GeneFamily | RNA binding motif containing | 1.82e-04 | 213 | 10 | 3 | 725 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 3.06e-09 | 199 | 18 | 6 | M7607 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 8.56e-09 | 432 | 18 | 7 | M41149 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 7.69e-08 | 166 | 18 | 5 | M8129 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 1.09e-07 | 363 | 18 | 6 | M41103 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 1.90e-07 | 680 | 18 | 7 | M41089 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 1.94e-07 | 200 | 18 | 5 | M9472 | |
| Coexpression | OSMAN_BLADDER_CANCER_UP | 6.02e-06 | 402 | 18 | 5 | M5275 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2 | 8.19e-06 | 58 | 18 | 3 | M2021 | |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 8.90e-06 | 198 | 18 | 4 | M7605 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP | 9.26e-06 | 200 | 18 | 4 | M4524 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2 | 9.55e-06 | 61 | 18 | 3 | MM869 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 1.16e-05 | 212 | 18 | 4 | MM3816 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 1.32e-05 | 219 | 18 | 4 | M41199 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 1.62e-04 | 417 | 18 | 4 | M39224 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 1.83e-04 | 822 | 18 | 5 | M6782 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 1.90e-04 | 166 | 18 | 3 | M6826 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 2.07e-04 | 171 | 18 | 3 | M5655 | |
| Coexpression | GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP | 2.91e-04 | 192 | 18 | 3 | M7558 | |
| Coexpression | GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP | 3.05e-04 | 195 | 18 | 3 | M3098 | |
| Coexpression | GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP | 3.09e-04 | 196 | 18 | 3 | M4532 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 3.14e-04 | 197 | 18 | 3 | M3193 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP | 3.19e-04 | 198 | 18 | 3 | M5293 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 3.28e-04 | 200 | 18 | 3 | M9449 | |
| Coexpression | GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN | 3.28e-04 | 200 | 18 | 3 | M4136 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP | 3.28e-04 | 200 | 18 | 3 | M4313 | |
| Coexpression | EHLERS_ANEUPLOIDY_UP | 3.42e-04 | 40 | 18 | 2 | M7775 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 4.39e-04 | 221 | 18 | 3 | M39222 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 8.99e-04 | 656 | 18 | 4 | M18979 | |
| Coexpression | TBK1.DF_DN | 9.29e-04 | 286 | 18 | 3 | M2864 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 1.33e-03 | 79 | 18 | 2 | M7102 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 2.28e-08 | 404 | 18 | 7 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.65e-08 | 413 | 18 | 7 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | 9.14e-08 | 770 | 18 | 8 | gudmap_developingGonad_P2_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.35e-07 | 151 | 18 | 5 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_100 | 1.85e-07 | 14 | 18 | 3 | gudmap_developingGonad_e16.5_epididymis_100_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_100 | 6.37e-07 | 83 | 18 | 4 | gudmap_developingGonad_e18.5_epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100 | 6.68e-07 | 84 | 18 | 4 | gudmap_developingGonad_e14.5_ epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 6.89e-07 | 403 | 18 | 6 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.96e-07 | 210 | 18 | 5 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 7.20e-07 | 406 | 18 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_100 | 7.35e-07 | 86 | 18 | 4 | gudmap_developingGonad_e16.5_epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.78e-07 | 225 | 18 | 5 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.09e-06 | 230 | 18 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.19e-06 | 97 | 18 | 4 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 1.90e-06 | 109 | 18 | 4 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 1.93e-06 | 778 | 18 | 7 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 2.14e-06 | 790 | 18 | 7 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 2.23e-06 | 795 | 18 | 7 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 2.26e-06 | 797 | 18 | 7 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 2.30e-06 | 799 | 18 | 7 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 2.34e-06 | 801 | 18 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 2.44e-06 | 806 | 18 | 7 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 2.63e-06 | 815 | 18 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.75e-06 | 323 | 18 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 6.78e-06 | 150 | 18 | 4 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 7.14e-06 | 152 | 18 | 4 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_200 | 7.72e-06 | 155 | 18 | 4 | gudmap_developingGonad_e16.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_200 | 7.92e-06 | 156 | 18 | 4 | gudmap_developingGonad_e12.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_200 | 8.12e-06 | 157 | 18 | 4 | gudmap_developingGonad_P2_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200 | 8.54e-06 | 159 | 18 | 4 | gudmap_developingGonad_e12.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 8.97e-06 | 161 | 18 | 4 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200 | 8.97e-06 | 161 | 18 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 1.01e-05 | 166 | 18 | 4 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 1.01e-05 | 166 | 18 | 4 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 1.04e-05 | 167 | 18 | 4 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 1.38e-05 | 387 | 18 | 5 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 1.38e-05 | 387 | 18 | 5 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 1.52e-05 | 395 | 18 | 5 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 1.78e-05 | 61 | 18 | 3 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 1.80e-05 | 409 | 18 | 5 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_500 | 1.89e-05 | 8 | 18 | 2 | gudmap_developingGonad_e11.5_testes and mesonephros_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_200 | 2.06e-05 | 64 | 18 | 3 | gudmap_developingGonad_e16.5_ovary_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200 | 2.16e-05 | 65 | 18 | 3 | gudmap_developingGonad_e12.5_ovary_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 2.16e-05 | 65 | 18 | 3 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 2.43e-05 | 9 | 18 | 2 | gudmap_developingGonad_e11.5_testes_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200 | 2.59e-05 | 69 | 18 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k5_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 2.98e-05 | 776 | 18 | 6 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_100 | 3.46e-05 | 76 | 18 | 3 | gudmap_developingGonad_e12.5_epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 3.63e-05 | 804 | 18 | 6 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.96e-05 | 249 | 18 | 4 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.78e-05 | 259 | 18 | 4 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#3_top-relative-expression-ranked_200 | 7.08e-05 | 15 | 18 | 2 | gudmap_developingGonad_e12.5_testes_k3_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.08e-05 | 15 | 18 | 2 | gudmap_developingGonad_e11.5_testes and mesonephros_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_100 | 7.08e-05 | 15 | 18 | 2 | gudmap_developingGonad_e18.5_epididymis_100_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_100 | 7.08e-05 | 15 | 18 | 2 | gudmap_developingGonad_e12.5_epididymis_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.30e-05 | 275 | 18 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.94e-05 | 281 | 18 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 8.09e-05 | 101 | 18 | 3 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 9.61e-05 | 107 | 18 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.03e-04 | 18 | 18 | 2 | gudmap_developingGonad_e11.5_testes_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_200 | 1.15e-04 | 19 | 18 | 2 | gudmap_developingGonad_e16.5_epididymis_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#5_top-relative-expression-ranked_500 | 1.70e-04 | 23 | 18 | 2 | gudmap_developingGonad_e12.5_testes_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 1.95e-04 | 136 | 18 | 3 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200 | 2.18e-04 | 26 | 18 | 2 | gudmap_developingGonad_e18.5_ovary_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_500 | 2.35e-04 | 27 | 18 | 2 | gudmap_developingGonad_P2_testes_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_200 | 2.46e-04 | 147 | 18 | 3 | gudmap_developingGonad_e18.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 2.51e-04 | 379 | 18 | 4 | gudmap_developingGonad_P2_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 2.58e-04 | 382 | 18 | 4 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | 3.26e-04 | 406 | 18 | 4 | gudmap_developingGonad_e12.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 3.27e-04 | 162 | 18 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_100 | 3.32e-04 | 32 | 18 | 2 | gudmap_developingGonad_e18.5_epididymis_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_200 | 3.45e-04 | 165 | 18 | 3 | gudmap_developingGonad_e12.5_testes_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 3.61e-04 | 417 | 18 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 3.90e-04 | 172 | 18 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_500 | 4.20e-04 | 36 | 18 | 2 | gudmap_developingGonad_P2_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 4.23e-04 | 435 | 18 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 4.62e-04 | 814 | 18 | 5 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | 4.75e-04 | 819 | 18 | 5 | gudmap_developingGonad_e16.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | 4.75e-04 | 819 | 18 | 5 | gudmap_developingGonad_P2_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | 4.83e-04 | 822 | 18 | 5 | gudmap_developingGonad_e14.5_ testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.94e-04 | 39 | 18 | 2 | gudmap_developingGonad_e18.5_testes_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_200 | 5.19e-04 | 40 | 18 | 2 | gudmap_developingGonad_P2_epididymis_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.46e-04 | 41 | 18 | 2 | gudmap_developingGonad_P2_testes_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.71e-04 | 196 | 18 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.73e-04 | 42 | 18 | 2 | gudmap_developingGonad_e12.5_testes_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#2_top-relative-expression-ranked_500 | 6.00e-04 | 43 | 18 | 2 | gudmap_developingGonad_e12.5_testes_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 6.58e-04 | 45 | 18 | 2 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_100 | 7.48e-04 | 48 | 18 | 2 | gudmap_developingGonad_e14.5_ epididymis_100_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 7.80e-04 | 49 | 18 | 2 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#1_top-relative-expression-ranked_500 | 7.80e-04 | 49 | 18 | 2 | gudmap_developingGonad_e14.5_ testes_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#5 | 9.12e-04 | 53 | 18 | 2 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.12e-03 | 564 | 18 | 4 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.13e-03 | 59 | 18 | 2 | gudmap_developingGonad_e16.5_testes_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_200 | 1.33e-03 | 64 | 18 | 2 | gudmap_developingGonad_e18.5_epididymis_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.45e-03 | 67 | 18 | 2 | gudmap_developingGonad_e12.5_testes_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 1.45e-03 | 67 | 18 | 2 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_100 | 1.50e-03 | 68 | 18 | 2 | gudmap_developingGonad_e12.5_ovary_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.55e-03 | 277 | 18 | 3 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.66e-03 | 284 | 18 | 3 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 1.67e-03 | 72 | 18 | 2 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.25e-08 | 197 | 18 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-08 | 200 | 18 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 9.39e-07 | 192 | 18 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.39e-07 | 192 | 18 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.58e-07 | 193 | 18 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.04e-06 | 197 | 18 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.04e-06 | 197 | 18 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-06 | 198 | 18 | 4 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-06 | 199 | 18 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.09e-05 | 135 | 18 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.69e-05 | 147 | 18 | 3 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.91e-05 | 151 | 18 | 3 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 3'_v3-lymph-node_spleen|World / Manually curated celltypes from each tissue | 4.22e-05 | 171 | 18 | 3 | 7aae88da5b37c20f10118325a048f08906be994c | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 4.76e-05 | 178 | 18 | 3 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.51e-05 | 187 | 18 | 3 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 188 | 18 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.68e-05 | 189 | 18 | 3 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.86e-05 | 191 | 18 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 192 | 18 | 3 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.96e-05 | 192 | 18 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 193 | 18 | 3 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 193 | 18 | 3 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 194 | 18 | 3 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 194 | 18 | 3 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.33e-05 | 196 | 18 | 3 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.43e-05 | 197 | 18 | 3 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.43e-05 | 197 | 18 | 3 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | Healthy_donor|World / disease group, cell group and cell class (v2) | 6.52e-05 | 198 | 18 | 3 | 1ed0b50c9754727a05c27b21f3546bf2e37eef7f | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.52e-05 | 198 | 18 | 3 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.62e-05 | 199 | 18 | 3 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 6.62e-05 | 199 | 18 | 3 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 6.62e-05 | 199 | 18 | 3 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.62e-05 | 199 | 18 | 3 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 6.72e-05 | 200 | 18 | 3 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 6.72e-05 | 200 | 18 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.93e-04 | 82 | 18 | 2 | 6875a10abf1221b3dfd954c319b5e8e12fac1ff2 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.93e-04 | 82 | 18 | 2 | 259bb4ae0373d8352cb1c3bff08f66b89a298440 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.93e-04 | 82 | 18 | 2 | 89aff8676f98e062d0e69b38c7184e51aa1a915e | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.32e-03 | 135 | 18 | 2 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.32e-03 | 135 | 18 | 2 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-03 | 154 | 18 | 2 | 71d33b5dbfab5820e3daddb01806a69116ba8008 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.76e-03 | 156 | 18 | 2 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.76e-03 | 156 | 18 | 2 | 7e6805ebc7bc2f9c5965321d16922c155719970f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like-IPs_and_early_cortical_neurons|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.76e-03 | 156 | 18 | 2 | 741de05295b2d012ac8576378f37709a97c8fb50 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-03 | 160 | 18 | 2 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-03 | 160 | 18 | 2 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-03 | 161 | 18 | 2 | 537a1d86de99a493b0345ca0f760994260e97049 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-03 | 161 | 18 | 2 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.90e-03 | 162 | 18 | 2 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-03 | 164 | 18 | 2 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-03 | 164 | 18 | 2 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | droplet-Marrow-BM-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-03 | 169 | 18 | 2 | 8e7a30eb546fc6fa184ebb76f54b74b278005a84 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-03 | 170 | 18 | 2 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.11e-03 | 171 | 18 | 2 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-03 | 175 | 18 | 2 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | (03)_Secretory-(4)_1wkpi|(03)_Secretory / shred by cell type and Timepoint | 2.21e-03 | 175 | 18 | 2 | 06b52f85baa31b55bb31477244892b6da79fe2c9 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-03 | 180 | 18 | 2 | 368ff7fcfd21ad248f96a83a8b191040ba7d8670 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-03 | 182 | 18 | 2 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-03 | 183 | 18 | 2 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-03 | 183 | 18 | 2 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.44e-03 | 184 | 18 | 2 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.46e-03 | 185 | 18 | 2 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 2.46e-03 | 185 | 18 | 2 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 187 | 18 | 2 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Mild/Remission-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.54e-03 | 188 | 18 | 2 | 614032d18f8060bb12d1af7a1cf1cf4d8b2b505b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.54e-03 | 188 | 18 | 2 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.57e-03 | 189 | 18 | 2 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-03 | 189 | 18 | 2 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.57e-03 | 189 | 18 | 2 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.62e-03 | 191 | 18 | 2 | a073d58154c801ec499fd969f42b7f1ee7f15d79 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.62e-03 | 191 | 18 | 2 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-03 | 191 | 18 | 2 | 08be56a4055a73c920d345fd3b2052a5ccb675d8 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.65e-03 | 192 | 18 | 2 | 48d557071bad80edd3ec6e5ad8dcd97037da9553 | |
| ToppCell | droplet-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-03 | 193 | 18 | 2 | cba070019db30604ebddb610eedf92e48221ac58 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.68e-03 | 193 | 18 | 2 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-03 | 193 | 18 | 2 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.68e-03 | 193 | 18 | 2 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-03 | 193 | 18 | 2 | 07ddb9525b686c31fa7df4286557d1e58f7ead52 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.70e-03 | 194 | 18 | 2 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.73e-03 | 195 | 18 | 2 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.73e-03 | 195 | 18 | 2 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-03 | 195 | 18 | 2 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 2.73e-03 | 195 | 18 | 2 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-03 | 195 | 18 | 2 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-03 | 195 | 18 | 2 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.73e-03 | 195 | 18 | 2 | dc84a910b6f6eb9994cd683aa4fd813a82198e5f | |
| ToppCell | Mild/Remission|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.76e-03 | 196 | 18 | 2 | 71603a3b7df40eb3f267345f55e44a812fea7926 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.76e-03 | 196 | 18 | 2 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | 3'|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-03 | 196 | 18 | 2 | 44007f0c14e0f0703f7ee715b8eababb4d80a8b5 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 2.76e-03 | 196 | 18 | 2 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.79e-03 | 197 | 18 | 2 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.79e-03 | 197 | 18 | 2 | 31dfd9842410b5c629f39b5130233995dceb0aef | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.81e-03 | 198 | 18 | 2 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 2.81e-03 | 198 | 18 | 2 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.81e-03 | 198 | 18 | 2 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.81e-03 | 198 | 18 | 2 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-03 | 198 | 18 | 2 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.81e-03 | 198 | 18 | 2 | 33a3b279c9ff3b762e52d060dae062167ca2239b | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.81e-03 | 198 | 18 | 2 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.81e-03 | 198 | 18 | 2 | 44417089b62056269cac38d3134ff209c05b7007 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.33e-05 | 50 | 14 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Neighborhood of ZNF198 | 4.19e-04 | 117 | 14 | 3 | GCM_ZNF198 | |
| Computational | Neighborhood of DFFA | 5.58e-04 | 129 | 14 | 3 | GCM_DFFA | |
| Computational | Neighborhood of GSPT1 | 1.22e-03 | 169 | 14 | 3 | GCM_GSPT1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1 | |
| Computational | Neighborhood of DDX5 | 2.94e-03 | 63 | 14 | 2 | GNF2_DDX5 | |
| Computational | Neighborhood of RBBP6 | 3.62e-03 | 70 | 14 | 2 | GNF2_RBBP6 | |
| Computational | Neighborhood of SUFU | 4.36e-03 | 77 | 14 | 2 | GCM_SUFU | |
| Computational | Neighborhood of RBM8A | 4.81e-03 | 81 | 14 | 2 | GCM_RBM8A | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.86e-07 | 188 | 18 | 5 | 6735_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.34e-07 | 194 | 18 | 5 | 4312_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.04e-05 | 179 | 18 | 4 | 4585_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.23e-05 | 187 | 18 | 4 | 4302_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 1.26e-05 | 188 | 18 | 4 | 4310_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.34e-05 | 191 | 18 | 4 | 4269_DN | |
| Drug | benz(a)anthracene | 2.85e-04 | 1251 | 18 | 6 | ctd:C030935 | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 3.29e-04 | 174 | 18 | 3 | 1302_UP | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.46e-04 | 177 | 18 | 3 | 985_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.52e-04 | 178 | 18 | 3 | 3998_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.63e-04 | 180 | 18 | 3 | 5981_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 4.00e-04 | 186 | 18 | 3 | 6874_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 4.26e-04 | 190 | 18 | 3 | 4306_DN | |
| Drug | Piracetam [7491-74-9]; Down 200; 28.2uM; MCF7; HT_HG-U133A | 4.32e-04 | 191 | 18 | 3 | 2861_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; HL60; HG-U133A | 4.59e-04 | 195 | 18 | 3 | 1370_UP | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A | 4.59e-04 | 195 | 18 | 3 | 1956_DN | |
| Drug | BW-B 70C; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 4.59e-04 | 195 | 18 | 3 | 1132_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 1662_DN | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; HL60; HG-U133A | 4.66e-04 | 196 | 18 | 3 | 1569_DN | |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.73e-04 | 197 | 18 | 3 | 825_DN | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 1828_DN | |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HG-U133A | 4.73e-04 | 197 | 18 | 3 | 1931_DN | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HG-U133A | 4.73e-04 | 197 | 18 | 3 | 1903_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 4301_UP | |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 2872_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.87e-04 | 199 | 18 | 3 | 1055_DN | |
| Drug | AC1LAD18 | 5.48e-04 | 44 | 18 | 2 | CID000466138 | |
| Disease | right ventricular diastolic volume measurement | 9.05e-05 | 28 | 15 | 2 | EFO_0021814 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HSRKRPRSRSCSESE | 971 | Q9ULD4 | |
| KRSHSKSPRRTRSRS | 266 | Q8IXT5 | |
| HSIKLSRRRSRSKSP | 116 | Q14498 | |
| HSRPRSSSVKRKRVS | 346 | Q8NEM0 | |
| STSSSKSRYRSKPRH | 576 | O43283 | |
| RSSRTPHSTRCRKED | 81 | Q9BZJ0 | |
| QKPHKSRSRSSSRSR | 456 | Q96S94 | |
| CSKSSVRSRRSSPKR | 101 | Q9HAZ1 | |
| CSSHQSRSKSHRRKR | 121 | Q9HAZ1 | |
| RSHSRSPSRCRTKSK | 936 | Q99590 | |
| SRSHSKNPKRSRSRE | 261 | Q9Y383 | |
| RTRSRSPKYHSSSKS | 766 | Q12872 | |
| RSRSKSRSSSKSGHR | 546 | P30414 | |
| VSHQSCSRSSRSKPR | 221 | A6PVC2 | |
| SRPRASSKEKAHSRS | 606 | B3KS81 | |
| RSHSKSRSRRRSKSP | 276 | Q05519 | |
| SRESKRHSSSKRRKS | 91 | A6NJ88 | |
| SSRSAIRHSPSKCRL | 1391 | O94964 | |
| KSRRRHSRRCSKTLC | 216 | A7MD48 | |
| TRLKSRASHTRTPSR | 256 | A8MUU9 | |
| SKSRASHTRTPSRAS | 366 | A8MUU9 | |
| RKKKHRRRSSSSSSS | 16 | Q96IZ7 | |
| SSRSSSPKRKKRHSR | 546 | Q8TF01 |